Global Imaging Agents Market To Record Excellent Growth With US$ 14,008.9 Million By 2030

January 2023 | Report Format: Electronic (PDF)

Imaging agents are a crucial part of medical imaging because they improve the visualization of internal organs during ultrasound, X-ray, MRI, and CT scans. Among other trends in the imaging agents market that have an impact on market expansion are nanoscale MRI contrast agents and Angio radioactive PET contrast agents. The market saw a minor reduction in revenue in 2020 as a result of the rising number of COVID-19 cases, travel restrictions, the restricted availability of hospitals, and fewer patient visits to imaging centers for imaging treatments.

However, starting in 2021, the governments of some nations began to lift travel restrictions and lockdowns. This action benefited the healthcare sector's recovery and had a beneficial effect on the imaging agent market. It expanded the use of imaging techniques, which raised demand. Imaging tools are used to assess cancer's stages (how far along it is), as well as whether it has spread to blood vessels or essential organs. The majority of cardiac MRI procedures also employ intravenous gadolinium-based contrast agents (GBAs) to improve the visibility of the heart muscle and blood flow. Gadolinium, microbubble, and iodine imaging agents are also needed for a rise in cancer imaging procedures for the thyroid, lung, and breast. As a result, the market revenue for imaging agents will increase due to the rising popularity of using imaging agents to pre-diagnose breast cancer and colorectal cancer.

North America has the biggest share of the Imaging Agents Industry, while Asia-Pacific is anticipated to develop at the quickest rate during the predicted period. There is a demand for imaging analysis in this area due to the rising prevalence of chronic diseases like breast cancer and cardiovascular and neurological conditions. Throughout the projection period, the region is anticipated to continue to dominate. During the projection period, technological advancements and the rising prevalence of chronic illnesses are expected to fuel growth.

Request a Free Sample Copy: Imaging Agents Market Report

Imaging Agents Market Report Highlights

• In May 2021, Lantheus received U.S. FDA approval for PYLARIFY, a PSMA PET imaging agent for prostate cancer. PYLARIFY injection helps to visualize bone, soft tissue, and lymph node metastases in order to detect whether recurrent or advanced prostate cancer is present. This novel strategy has helped the firm to improve its overall product portfolio.
• In May 2020, Eli Lilly and Company subsidiary Avid Radiopharmaceuticals, Inc., received U.S. FDA approval for TAUVID and AMYVID (Florbetapir F 18 Injection). This positron emission tomography (PET) imaging agent provides physicians with meaningful information on Alzheimer's disease. This approval helped the company to strengthen its imaging agent offerings and enhanced the company's revenue generation.

IMAGING AGENTS MARKET SEGMENTATION

The research report published by Market Research Strategy contains industry segments, as below-

Imaging Agents Type Outlook (Revenue, USD Million, 2017 - 2030)

• Iodinated Contrast Media
• Gadolinium-based Contrast Media
• Microbubble Contrast Media
• Barium-based Contrast Media

Imaging Agents Application Outlook (Revenue, USD Million, 2017 - 2030)

• Oncology
• Cardiology
• Gastrointestinal
• Neurology
• Others

Imaging Agents Modality Outlook (Revenue, USD Million, 2017 - 2030)

• X-Ray
• Computed Tomography (CT)
• Magnetic Resonance Imaging (MRI)
• Ultrasound
• Others

Imaging Agents Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America (U.S., and Canada)
• Europe (Germany, U.K., France, Italy, Spain etc.)
• Asia-Pacific (China, India, Japan, Indonesia, Malaysia, Australia, South Korea, etc.)
• South America (Brazil, Mexico, Argentina etc.)
• Middle East & Africa (Saudi Arabia, Kuwait, UAE, South Africa etc.)

List of Key Players- Imaging Agents Market

• Eurofins Scientific
• GE Healthcare
• Eli Lily
• Bayer Healthcare Pharmaceuticals
• Alliance Medical
• Bracco Diagnostics, Inc.
• Aytu BioScience, Inc.
• Curium
• Guerbet Group
• Lantheus Medical Imaging, Inc.
• Trivitron Healthcare
• Beijing Beilu Pharmaceutical

About Market Research Strategy:

Market Research Strategy (MRS) is a dedicated and disciplined market research firm that delivers authentic consulting services with accurate data forecasting for research-related services. The positive and result-oriented approaches implemented by us are beneficial in identifying the market challenges of any brand or start-up company to penetrate the competitive business space.

MRS also supports numerous organizations with its syndicate data and research reports to establish and survive in the market by grabbing the available market opportunities. Our vast experience and huge client database turn out to be our wealth and also secures our market position at the top of the list. Besides, we make use of every single piece of information, mined from authentic sources, into a valuable asset of the report; aiding our clients with informed business decisions.

Contact Us:

Market Research Strategy

76 Kennington Road,

London SE11 6NL,

United Kingdom

USA Phone: +1 9176726599

Business Email: sales@marketresearchstrategy.com

Website: https://marketresearchstrategy.com/